TY - JOUR
T1 - The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels
AU - Ramos, Christian G.
AU - Carvahal, Gustavo F.
AU - Mager, Douglas E.
AU - Haberer, Beth
AU - Catalona, William J.
PY - 1999/11
Y1 - 1999/11
N2 - Purpose: It is established that the percentage of free prostate specific antigen (PSA) in serum is low in patients with prostate cancer. An unanswered question is whether a low percentage of free PSA can be explained by high grade prostatic intraepithelial neoplasia alone. We compared the percentage of free PSA in men with high grade prostatic intraepithelial neoplasia alone, prostate cancer, benign prostatic hyperplasia (BPH) and a normal prostate (that is normal digital rectal examination and PSA less than or equal to 2.5 ng./ml.). Materials and Methods: From October 1994 through December 1997, 48 men were diagnosed with high grade prostatic intraepithelial neoplasia without concomitant prostate cancer. Of these men 43 with a mean age plus or minus standard deviation of 67.4 ± 7.8 years comprised our study group. To date none has been diagnosed with cancer during followup. Serum free and total PSA levels were measured, and the percentage of free PSA was calculated. The percentage of free PSA in the 43 men was compared to that in 50 with prostate cancer (mean age 65.4 ± 7.8 years), 50 with biopsy proved BPH (67 ± 7) and 43 with a normal prostate (61 ± 8). Results: There was no significant difference in mean total serum PSA in patients with high grade prostatic intraepithelial neoplasia, prostate cancer or BPH. The percentage of free PSA was significantly lower in patients with prostate cancer (14.9 ± 6.5%) than those with high grade prostatic intraepithelial neoplasia (20.8 ± 7.1%), BPH (20.1 ± 7.3%) or a normal prostate (27.7 ± 12.2%). There was also no significant difference in the percentage of free PSA between men with high grade prostatic intraepithelial neoplasia (20.8 ± 7.1%) and those with BPH (20.1 ± 7.3%). Additionally, men with a normal prostate had a higher percentage of free PSA (27.7%) than those with BPH (20.1%), high grade prostatic intraepithelial neoplasia (20.8%) or prostate cancer (14.9%). Conclusions: The percentages of free PSA in men with high grade prostatic intraepithelial neoplasia and BPH are similar, and significantly higher than those found in men with prostate cancer.
AB - Purpose: It is established that the percentage of free prostate specific antigen (PSA) in serum is low in patients with prostate cancer. An unanswered question is whether a low percentage of free PSA can be explained by high grade prostatic intraepithelial neoplasia alone. We compared the percentage of free PSA in men with high grade prostatic intraepithelial neoplasia alone, prostate cancer, benign prostatic hyperplasia (BPH) and a normal prostate (that is normal digital rectal examination and PSA less than or equal to 2.5 ng./ml.). Materials and Methods: From October 1994 through December 1997, 48 men were diagnosed with high grade prostatic intraepithelial neoplasia without concomitant prostate cancer. Of these men 43 with a mean age plus or minus standard deviation of 67.4 ± 7.8 years comprised our study group. To date none has been diagnosed with cancer during followup. Serum free and total PSA levels were measured, and the percentage of free PSA was calculated. The percentage of free PSA in the 43 men was compared to that in 50 with prostate cancer (mean age 65.4 ± 7.8 years), 50 with biopsy proved BPH (67 ± 7) and 43 with a normal prostate (61 ± 8). Results: There was no significant difference in mean total serum PSA in patients with high grade prostatic intraepithelial neoplasia, prostate cancer or BPH. The percentage of free PSA was significantly lower in patients with prostate cancer (14.9 ± 6.5%) than those with high grade prostatic intraepithelial neoplasia (20.8 ± 7.1%), BPH (20.1 ± 7.3%) or a normal prostate (27.7 ± 12.2%). There was also no significant difference in the percentage of free PSA between men with high grade prostatic intraepithelial neoplasia (20.8 ± 7.1%) and those with BPH (20.1 ± 7.3%). Additionally, men with a normal prostate had a higher percentage of free PSA (27.7%) than those with BPH (20.1%), high grade prostatic intraepithelial neoplasia (20.8%) or prostate cancer (14.9%). Conclusions: The percentages of free PSA in men with high grade prostatic intraepithelial neoplasia and BPH are similar, and significantly higher than those found in men with prostate cancer.
KW - Prostate- specific antigen
KW - Prostatic intraepithelial neoplasia
KW - Prostatic neoplasms
UR - http://www.scopus.com/inward/record.url?scp=0032876802&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032876802&partnerID=8YFLogxK
U2 - 10.1016/S0022-5347(05)68172-4
DO - 10.1016/S0022-5347(05)68172-4
M3 - Article
C2 - 10524873
AN - SCOPUS:0032876802
SN - 0022-5347
VL - 162
SP - 1587
EP - 1590
JO - Journal of Urology
JF - Journal of Urology
IS - 5
ER -